India, with its diverse climatic conditions and high population density, is a hotbed for vector-borne diseases (VBDs). These diseases, transmitted through insects such as mosquitoes, ticks, and fleas, pose a significant public health challenge, affecting millions annually.
India's VBDs landscape is dominated by malaria, dengue, chikungunya, and Japanese encephalitis. Malaria alone accounts for 88% of the Southeast Asia's burden. Dengue, with its rapid urban spread, has seen a 300% increase in the last five years. Chikungunya, though less lethal, causes debilitating joint pains affecting productivity. Japanese encephalitis, though region-specific, has a high mortality rate.
Multiple factors contribute to the VBD burden in India. Rapid urbanization and inadequate sanitation lead to breeding grounds for vectors. Climate change exacerbates the situation by expanding the vectors' geographical range. Additionally, the lack of public awareness and insufficient healthcare infrastructure hinder disease control efforts.
India's National Vector Borne Disease Control Programme (NVBDCP) is the central nodal agency for prevention and control of VBDs. Its strategies include early case detection, prompt treatment, integrated vector management, and public awareness campaigns. However, these strategies need strengthening through better implementation and regular monitoring.
Healthcare professionals play a crucial role in managing VBDs. Their tasks include early diagnosis, appropriate treatment, and patient education. Additionally, they can contribute to research for better diagnostic tools and treatments. Their role in policy advocacy for improved healthcare infrastructure and sanitation is equally important.
Vector-borne diseases remain a significant health challenge in India. A multifaceted approach involving improved sanitation, public awareness, robust healthcare infrastructure, and active involvement of healthcare professionals is necessary to alleviate this burden. Ongoing research and policy changes are essential to pave the way for a healthier India.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation